We are live on
!
Find out more
Invesco Pharmaceuticals ETF
PJP
PJP
79 hedge funds and large institutions have $58.2M invested in Invesco Pharmaceuticals ETF in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 20 increasing their positions, 21 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
1.55% more ownership
Funds ownership: 17.35% → 18.9% (+1.5%)
5% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 21
5% less capital invested
Capital invested by funds: $61.3M → $58.2M (-$3.13M)
10% less funds holding
Funds holding: 88 → 79 (-9)
60% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 15
Holders
79
Holders Change
-9
Holders Change %
-10.23%
% of All Funds
1.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
20
Reduced
21
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$6.39M |
| 2 |
Wells Fargo
San Francisco,
California
|
+$634K |
| 3 |
FTUS
Flow Traders U.S.
New York
|
+$231K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$215K |
| 5 |
MPCG
Matrix Private Capital Group
New York
|
+$166K |
